Font, J.; Hodzic, A.; Da-Silva, A.; Delapierre, B.; Damaj, G.; Neusy, A.; Plane, A.-F.; Legallois, D.; Milliez, P.; Dolladille, C.;
et al. Association Between the Renin–Angiotensin System and Ibrutinib-Related Cardiovascular Adverse Events: A Translational Cohort Study. Biomedicines 2025, 13, 2184.
https://doi.org/10.3390/biomedicines13092184
AMA Style
Font J, Hodzic A, Da-Silva A, Delapierre B, Damaj G, Neusy A, Plane A-F, Legallois D, Milliez P, Dolladille C,
et al. Association Between the Renin–Angiotensin System and Ibrutinib-Related Cardiovascular Adverse Events: A Translational Cohort Study. Biomedicines. 2025; 13(9):2184.
https://doi.org/10.3390/biomedicines13092184
Chicago/Turabian Style
Font, Jonaz, Amir Hodzic, Angélique Da-Silva, Baptiste Delapierre, Ghandi Damaj, Anne Neusy, Anne-Flore Plane, Damien Legallois, Paul Milliez, Charles Dolladille,
and et al. 2025. "Association Between the Renin–Angiotensin System and Ibrutinib-Related Cardiovascular Adverse Events: A Translational Cohort Study" Biomedicines 13, no. 9: 2184.
https://doi.org/10.3390/biomedicines13092184
APA Style
Font, J., Hodzic, A., Da-Silva, A., Delapierre, B., Damaj, G., Neusy, A., Plane, A.-F., Legallois, D., Milliez, P., Dolladille, C., Vernon, M., Burton, S., Vigneron, N., Denoyelle, C., & Alexandre, J.
(2025). Association Between the Renin–Angiotensin System and Ibrutinib-Related Cardiovascular Adverse Events: A Translational Cohort Study. Biomedicines, 13(9), 2184.
https://doi.org/10.3390/biomedicines13092184
